The committee discussed the Ensuring Timely Access to Generics Act, the Expanding Access to Low-Cost Generics Act, the Retaining Access and Restoring Exclusivity Act, and the Pharmacy Benefit Manager Reform Act after delaying a markup meeting scheduled for May 2.
Among the 21 committee members, a majority voted for the amended bills to advance.
Register to Attend Webinar
Presenters:
Frank Stevens, Strata|Josh Wiggins, Strata
Next Up in Legal & Regulatory Issues
-
House Democrats have drafted an 84-page health policy agenda outlining what the party would pursue if it wins a House…
-
Adventist Health Sonora (Calif.) has reached a settlement of $18.5 million with seven women who alleged sexual abuse from physical…
-
CMS is working with 37 states on quality measurement in Medicaid and the Children’s Health Insurance Program, the agency shared…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
